Clinical Trial Update: OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

View source ↗

Summary

The document reports a clinical trial update where exosome-based OCS products are being used for recurrence monitoring after initial treatment in CA125-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• OCS products based on exosome technology

Snippet

Sponsor: Beihua Kong | Conditions: Ovarian Cancer | Status: NOT_YET_RECRUITING